The Lung Microbiota Affects Pulmonary Inflammation and Oxidative Stress Induced by PM2.5 Exposure

Simin Wang1, Qixing Zhou1, Yingze Tian2

  • 1Key Laboratory of Pollution Processes and Environmental Criteria (Ministry of Education)/Tianjin Key Laboratory of Environmental Remediation and Pollution Control, College of Environmental Science and Engineering, Nankai University, Tianjin 300350, China.

Insights

Exposure to fine particulate matter (PM2.5) alters lung bacteria, increasing inflammation and oxidative stress. Restoring lung microbiota balance may mitigate PM2.5-induced respiratory damage.

Area of Science:

  • Environmental Health
  • Microbiology
  • Pulmonology

Background:

  • Fine particulate matter (PM2.5) exposure is a known cause of respiratory diseases, linked to inflammation and oxidative stress.
  • The role of the pulmonary microbiota in mediating PM2.5-induced lung pathology remains unclear.

Purpose of the Study:

  • To investigate the hypothesis that the lung microbiota influences pulmonary inflammation and oxidative stress resulting from PM2.5 exposure.
  • To elucidate the relationship between PM2.5-induced changes in the pulmonary microbiota and subsequent lung damage.

Main Methods:

  • Mice were exposed to PM2.5 intranasally, followed by pulmonary microbiota transfer and antibiotic interventions.
  • Histological examinations, biomarker detection, and transcriptome analyses were performed.
  • 16S rRNA gene sequencing characterized the pulmonary microbiota composition and diversity.

Main Results:

  • PM2.5 exposure significantly reduced pulmonary microbiota diversity, increasing Proteobacteria and decreasing Bacteroidota abundance.
  • Altered microbiota composition correlated with increased pulmonary inflammation and oxidative stress markers.
  • Microbiota transfer from exposed mice exacerbated PM2.5 effects, while antibiotic treatment alleviated them, restoring microbial balance.

Conclusions:

  • Pulmonary microbial dysbiosis promotes and exacerbates inflammation and oxidative stress during PM2.5 exposure.
  • Modulating the lung microbiota represents a potential therapeutic strategy for mitigating PM2.5-related respiratory diseases.